Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Expansion Driven By Rising Personalized Medicine Adoption And Targeted Genetic Detection
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Compare Between 2026 And 2030?
The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market size has experienced swift expansion in recent years. It is projected to grow from $1.57 billion in 2025 to $1.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.3%. This historical growth can be attributed to the rising demand for rapid molecular diagnostics, the adoption of cas9-based detection tools, the proliferation of academic and research institutes, the expansion of pharmaceutical and biotechnology research, and the increasing prevalence of genetic research initiatives.
The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market size is anticipated to undergo significant expansion in the next few years. It is projected to reach $3.83 billion by 2030, showing a compound annual growth rate (CAGR) of 19.5%. This growth over the forecast period is driven by factors such as the increasing adoption of multiplex and high-throughput assays, greater integration with AI-enabled analysis platforms, a surging demand for point-of-care diagnostics, the broadening of clinical laboratory capabilities, and a heightened focus on personalized medicine applications. Major trends anticipated during this period include the wider implementation of multiplex CRISPR fluorescence assays, an escalating demand for Cas12 and Cas13-based detection technologies, the growing incorporation of real-time fluorescence readers, the expansion of their use in diagnostic and drug discovery, and an increased emphasis on detecting pathogens and biomarkers with high sensitivity.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Major Drivers Are Influencing The Expansion Of The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market?
The increasing demand for personalized medicine is anticipated to fuel the expansion of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market going forward. This approach involves customizing healthcare, including treatment and prevention strategies, to match a person’s unique genetic makeup, environmental factors, and lifestyle for the best possible results. Its expansion stems from the growing incidence of chronic conditions, necessitating targeted treatments that are more efficacious for individual patients compared to conventional methods. Clustered regularly interspaced short palindromic repeats fluorescence assays support personalized medicine by offering quick and highly precise identification of genetic mutations or biomarkers within a patient’s DNA, empowering physicians to pinpoint disease-causing variations and customize therapies according to the individual’s genetic profile. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA sanctioned 16 novel personalized treatments for rare disease patients, an increase from six in 2022. Consequently, the increasing inclination towards personalized medicine is stimulating the expansion of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market.
How Is The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Organized By Segment Classification?
The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments, Other Product Types
2) By Technology: Cas9-Based Fluorescence Assays, Cas12-Based Fluorescence Assays, Cas13-Based Assays, Other Technologies
3) By Detection: Fluorescence-Based, Lateral Flow
4) By Application: Gene Editing, Diagnostics, Drug Discovery, Other Applications
5) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users
Subsegments:
1) By Kits: Detection Kits, Editing Kits, Multiplex Kits
2) By Reagents: Cas Enzymes, Buffers And Solutions, Probes And Reporters
3) By Instruments: Fluorescence Readers, Real-Time PCR Instruments, Microplate Readers
4) By Other Product Types: Consumables, Accessories, Software
Who Are The Industry Participants Involved In The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market?
Major companies operating in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market are Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Ginkgo Bioworks, OriGene Technologies Inc., Synthego Corporation, Inscripta Inc., Mammoth Biosciences Inc., Creative Biolabs, Cellecta Inc., GeneCopoeia Inc., SBS Genetech Co. Ltd., Addgene, CrisprBits Private Limited.
Get The Full Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Report:
Where Is The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Primarily Concentrated By Region?
North America was the largest region in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market 2026, By The Business Research Company
connected health personal medical devices market report 2026
contract sterilization market report 2026
https://www.thebusinessresearchcompany.com/report/contract-sterilization-global-market-report
orthotic insole 3-d printer market report 2026
https://www.thebusinessresearchcompany.com/report/orthotic-insole-3-d-printer-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
